Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
It produced an average weight loss of 22.7% in its Phase 3 REDEFINE 1 trial, the highest reported for any Novo Nordisk obesity drug to date
Hers focuses on brand-name access through a simple cash-pay membership, while Josie was created for women navigating hormonal changes in midlife
A 4mg dose
Text or Call: 630-454-1300 References Pizzorno J
Wegovy (Semaglutide) FDA-approved, injectable weight loss medication FDA-approved, injectable weight loss medication Wegovy is specifically indicated for chronic weight management in adults with obesity or overweight conditions and works by activating the GLP-1 receptors to help reduce appetite and increase feelings of fullness ultimately contributing to weight loss
Therefore, there is little data on any long-term side effects of taking semaglutide
